Thanks for the heads up. I haven't yet had access to the body of the article, but judging from the abstract, it sounds as if the article supports the Resverlogix's hypothesis of Apabetalone restoring normal gene expression in diabetic patients.
The impact factor of the journal is quite high (8 or so) - (read: this is not just random musings from some wannabe scientists :D ).
BR.
BKC